DataMEDS AI, Inc. (MEDS) vs Quince Therapeutics, Inc. (QNCX)
A side-by-side comparison of DataMEDS AI, Inc. and Quince Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MEDS
DataMEDS AI, Inc.
$3.07HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
QNCX
Quince Therapeutics, Inc.
$26.81HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — MEDS vs QNCX
growth of $100 · dividends reinvested · last 7yMEDS -90.9% (-29.0%/yr)QNCX -99.6% (-54.1%/yr)MEDS compounded faster over this window
Log scale — wide-divergence pair
MEDS QNCX
MEDS vs QNCX: by the numbers
- •MEDS is the larger company ($8M vs $7M market cap).
- •Both run net losses; QNCX's is the smaller (0.00% vs -1100.30% net margin).
Metrics side by side
Valuation
| Metric | MEDS | QNCX |
|---|---|---|
| P/S ratio | 1.00 | N/A |
Profitability
| Metric | MEDS | QNCX |
|---|---|---|
| Gross margin | -41.30% | 0.00% |
| Operating margin | -347.91% | 0.00% |
| Net margin | -1100.30% | 0.00% |
| ROE | N/A | -85.24% |
| ROIC | -439.90% | -107.08% |
Growth (annualized)
| Metric | MEDS | QNCX |
|---|---|---|
| Total return CAGR (5Y) | -45.88% | -72.96% |
Frequently asked
- How have MEDS and QNCX total returns compared?
- Over the past 5 years, MEDS delivered -45.88% and QNCX delivered -72.96% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.